We speak to a wide range of pharmacists – from academics, to Guild leaders, to employed community pharmacists and hospital pharmacists – about the push to prescribe.
We cover topics like the potential conflict of interest, what might a prescribing model look like, should we instead focus on limited dose changes or better handling of S3 medicines, and many more
